POOR ERYTHROID ENGRAFTMENT

Clinical trials for POOR ERYTHROID ENGRAFTMENT explained in plain language.

Never miss a new study

Get alerted when new POOR ERYTHROID ENGRAFTMENT trials appear

Sign up with your email to follow new studies for POOR ERYTHROID ENGRAFTMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for blood cancer patients: drug may prevent post-transplant anemia

Disease control Not yet recruiting

This study tests whether the drug luspatercept can prevent severe anemia (low red blood cells) after a stem cell transplant in people with blood cancers who also have moderate to severe bone marrow scarring (myelofibrosis). About 196 adults aged 18-65 will be randomly assigned to…

Matched conditions: POOR ERYTHROID ENGRAFTMENT

Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated May 12, 2026 13:43 UTC

POOR ERYTHROID ENGRAFTMENT

Get alerted when new POOR ERYTHROID ENGRAFTMENT trials appear

New hope for blood cancer patients: drug may prevent post-transplant anemia